NEWS
2019
Labiotech refers to Kancera’s R&D presented at the World Congress of Cardiology/ESC (2019-10-07)
Commissioned analyst report of Kancera AB by Carlsquare (2019-05-29)
2018
Marie Sklodowska-Curie PhD student position at Kancera AB on the role of the fractalkine system in inflammatory conditions (2018-12-20).
Kancera chemistry contributed to one of the new drugs approved in 2017 against cancer (2018-02-01)
2017
Abstract to a presentation on ASH about KAN0439834 (2017-11-09)
The PFKFB3 project is presented at “The 6th EU-US conference on repair of endogenous DNA damage” (2017-09-24)
Kancera’s Fractalkine project appears in BIO Buzz (2017-06-27)
Drug Discovery Today covers Kancera’s Fractalkine project (2017-04-10)
Kancera project update February 2017
2015
Poster at ASH on ROR-inhibitors
Presentation by CEO Thomas Olin in Paris at BIO-Europe Spring 2015